UAE Strengthens access to innovative care with New Fibrosis Drug Approval
The Emirates Drug Establishment has approved Jascaydยฎ (nerandomilast) for the treatment of…
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZenecaโs Etcamah, a new oral therapy for advanced…
ย API China 2026 Highlights
Jurie Hwang, Director of Public & International Affairs at the Korea Biotechnology…
UAE Among First Globally to Approve New Obesity and Hypertension Treatments
The United Arab Emirates is strengthening its global leadership in healthcare innovation…
FDA Approves Merckโs NUMELVI for Allergic Dermatitis in Dogs
Merck Animal Health has received FDA approval for NUMELVIโข (atinvicitinib), a next-generation…
Visitor Insight Highlights | API Chongqing Expo 2025
Visitor Insight Highlights from API Chongqing Expo 2025 showcase industry perspectives on…
CPHI & BIO Middle East 2026 Rescheduled to December in Riyadh
CPHI & BIO Middle East 2026 has been rescheduled to December in…
Bayerโs Kerendia Gains EU Approval for Expanded Use in Heart Failure Treatment
Bayer receives European Commission approval to expand the use of Kerendia (finerenone)…
DUPHAT announces new dates for 2026 edition
The organisers of DUPHAT have confirmed the new dates for the 2026…
โAmbition Must Be Aligned with Responsibility in the Healthcare Systemโ
The Middle Eastโs position as a global healthcare leader continues to strengthen,…
